ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.113,01
0,36%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Turning Point Therapeutics Inc (TPTX)

  7. Turning Point Therapeutics Inc (TPTX) News

TPTX

Turning Point Therapeutics (TPTX)

Turning Point Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TPTX
DatumZeitQuelleÜberschriftSymbolFirma
29/08/202222h31Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:TPTXTurning Point Therapeutics Inc
23/08/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215h03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215h01Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215h01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202214h45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202213h11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202213h09Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202212h59Business WireBristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point TherapeuticsNASDAQ:TPTXTurning Point Therapeutics Inc
11/08/202205h20TipRanksAnalysts Offer Insights on Healthcare Companies: Reata Pharmaceuticals (RETA), Turning Point Therapeutics (TPTX) and Talkspace (TALK)NASDAQ:TPTXTurning Point Therapeutics Inc
10/08/202206h35TipRanksJMP Securities Remains a Hold on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
09/08/202213h07Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
08/08/202222h20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TPTXTurning Point Therapeutics Inc
08/08/202222h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPTXTurning Point Therapeutics Inc
08/08/202222h17GlobeNewswire Inc.Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational UpdatesNASDAQ:TPTXTurning Point Therapeutics Inc
01/08/202205h31TipRanksSVB Securities Maintains a Hold Rating on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
27/07/202222h05GlobeNewswire Inc.Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLCNASDAQ:TPTXTurning Point Therapeutics Inc
19/07/202213h29Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
19/07/202213h13Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TPTXTurning Point Therapeutics Inc
01/07/202222h12Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TPTXTurning Point Therapeutics Inc
01/07/202222h02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
24/06/202215h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPTXTurning Point Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TPTX

Kürzlich von Ihnen besucht

NASDAQ
GOOGL
Alphabet
FX
EURGBP
Euro vs Sterling
CCOM
SILVER
SILVER
COIN
ETHUSD
Ethereum
NYSE
MRK
Merck
NYSE
KO
Coca Cola
TG
D7G
Nel ASA
FX
EURJPY
Euro vs Yen
TG
LHA
Deutsche Lufthansa
TG
DTE
Deutsche Telekom
TG
BAYN
Bayer
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
NYSE
XOM
Exxon Mobil
NYSE
JPM
JP Morgan Chase
DBI
DAX
DAX
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten